Search research articles
Contact Us
Filters
Showing results (41-50 of 60) with videos related to
Page
of 6
Sort By:
CPT: Pharmacometrics & Systems Pharmacology
|
July 30, 2025
Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing
Wisse van Os, Amaury O'Jeanson, Carla Troisi, et al.
Clinical Pharmacokinetics
|
March 15, 2024
Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease
Nanja C Bevers, Ron J Keizer, Dennis R Wong, et al.
Frontiers in Pharmacology
|
May 16, 2020
Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children's Hospital
Adam Frymoyer, Hayden T Schwenk, Yvonne Zorn, et al.
Investigational New Drugs
|
August 21, 2008
Application of population pharmacokinetic modeling in early clinical development of the anticancer agent E7820
Ron J Keizer, Miren K Zamacona, Mendel Jansen, et al.
British Journal of Clinical Pharmacology
|
March 26, 2013
A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A
Anne-Kristina Frobel, Mats O Karlsson, Janne T Backman, et al.
European Journal of Clinical Pharmacology
|
August 17, 2024
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients
Astrid Heida, Nynke G L Jager, Rob E Aarnoutse, et al.
British Journal of Clinical Pharmacology
|
May 17, 2020
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients
Rob Ter Heine, Ron J Keizer, Krista van Steeg, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 24, 2010
A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080
Ron J Keizer, Anubha Gupta, Melvin R Mac Gillavry, et al.
Antimicrobial Agents and Chemotherapy
|
June 4, 2008
Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients
Thomas P C Dorlo, Pieter P A M van Thiel, Alwin D R Huitema, et al.
Clinical Pharmacokinetics
|
July 29, 2020
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
Tom C Zwart, Dirk Jan A R Moes, Paul J M van der Boog, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 60) with videos related to
Sort By:
Page
of 6
CPT: Pharmacometrics & Systems Pharmacology
|
July 30, 2025
Machine Learning-Based Model Selection and Averaging Outperform Single-Model Approaches for a Priori Vancomycin Precision Dosing
Wisse van Os, Amaury O'Jeanson, Carla Troisi, et al.
Clinical Pharmacokinetics
|
March 15, 2024
Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease
Nanja C Bevers, Ron J Keizer, Dennis R Wong, et al.
Frontiers in Pharmacology
|
May 16, 2020
Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children's Hospital
Adam Frymoyer, Hayden T Schwenk, Yvonne Zorn, et al.
Investigational New Drugs
|
August 21, 2008
Application of population pharmacokinetic modeling in early clinical development of the anticancer agent E7820
Ron J Keizer, Miren K Zamacona, Mendel Jansen, et al.
British Journal of Clinical Pharmacology
|
March 26, 2013
A time-to-event model for acute rejections in paediatric renal transplant recipients treated with ciclosporin A
Anne-Kristina Frobel, Mats O Karlsson, Janne T Backman, et al.
European Journal of Clinical Pharmacology
|
August 17, 2024
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients
Astrid Heida, Nynke G L Jager, Rob E Aarnoutse, et al.
British Journal of Clinical Pharmacology
|
May 17, 2020
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients
Rob Ter Heine, Ron J Keizer, Krista van Steeg, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
July 24, 2010
A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080
Ron J Keizer, Anubha Gupta, Melvin R Mac Gillavry, et al.
Antimicrobial Agents and Chemotherapy
|
June 4, 2008
Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients
Thomas P C Dorlo, Pieter P A M van Thiel, Alwin D R Huitema, et al.
Clinical Pharmacokinetics
|
July 29, 2020
Model-Informed Precision Dosing of Everolimus: External Validation in Adult Renal Transplant Recipients
Tom C Zwart, Dirk Jan A R Moes, Paul J M van der Boog, et al.
Page
of 6